Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Laurent Roten , Matthew Daly , Patrizio Pascale , et al Added: 3 years ago
With an ageing population and widespread use of implantable cardioverter-defibrillators, physicians are confronted with an increasing number of patients with symptomatic, drug-refractory ventricular tachycardia (VT). Catheter ablation is an important treatment option in the management of patients with structural heart disease and VT.1,2 In many patients, VT can be successfully ablated from the… View more
Author(s): Eduardo Back Sternick , Mariana Faustino , Frederico Soares Correa , et al Added: 3 years ago
Radiofrequency (RF) catheter ablation is currently the treatment of choice in patients with accessory pathways (APs) and Wolff– Parkinson–White syndrome, and is shown to have a success rate >95 %.1 APs usually have endocardial ventricular and atrial insertions, located close to the atrioventricular valve rings, making most endocardial catheter ablation procedures relatively straightforward and… View more
Author(s): Thorsten Hanke, MD Start date: Nov 18, 2017
This live stream will be presented during the following session: Session 9: Interesting and challenging cases Case 4, presented by Thorsten Hanke, MD Moderator: Lars Sondergaard, MD / Stefan Bertog, MD Panelist: Bushra Rana, MD / Vijay Swarup, MD View more
Author(s): Mario Njeim , Frank Bogun Added: 3 years ago
Percutaneous ablation for ventricular tachycardia (VT) was first attempted in 1983 and has rapidly evolved to become an important option for controlling recurrent VTs.1 Endocardial ablation remained the only percutaneous approach until epicardial access was introduced by Sosa et al. in 1996 and thereafter became progressively more available as an adjunctive strategy for the treatment of… View more
Author(s): Charles M Pearman , Shi S Poon , Laura J Bonnett , et al Added: 3 years ago
The goal of arrhythmia eradication in AF continues to be elusive for cardiac electrophysiologists. Although endocardial radiofrequency (RF) catheter ablation is more effective than pharmacological management at maintaining sinus rhythm,1 it is far from perfect, especially in patients with non-paroxysmal AF.2 In an attempt to address this, attention has turned back to the surgical ablation that… View more
Author(s): Amit J Thosani , Paul Gerczuk , Emerson Liu , et al Added: 3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide. In 2010, the prevalence of AF in the US was estimated at 5.9 million.1 The decision to pursue treatment to maintain sinus rhythm is driven by disabling symptoms related to AF; including palpitations, dyspnoea, fatigue, stroke and congestive heart failure. Percutaneous catheter-based ablation is an established therapy for… View more
Author(s): Ramanan Kumareswaran , Francis E Marchlinski Added: 3 years ago
Ventricular tachycardia (VT) is one of the most challenging medical conditions faced by cardiac patients and physicians treating them. Antiarrhythmic medications have limited effectiveness and are frequently poorly tolerated.1–4 Catheter ablation is increasingly used to treat patients successfully.1,5–7 Most VTs can be ablated endocardially but some require epicardial mapping and ablation… View more
Author(s): Karan Wats , Andy Kiser , Kevin Makati , et al Added: 3 years ago
AF is the most commonly encountered atrial arrhythmia in clinical practice. Restoration of normal sinus rhythm through catheter- and surgically based approaches has been increasingly used as technologies and outcomes have improved.1 Success rates for AF ablation vary greatly depending on the duration of AF (more successful for paroxysmal AF, less successful in persistent AF and even less so for… View more